Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Cancer|February 15, 1992
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinomaR Pazdur, J A Ajani, R Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG StudyH G Seydel, L Leichman, R Byhardt, et al.
Oncology|August 7, 1999
Fluoropyrimidines: a critical evaluationR A Brito, D Medgyesy, T H Zukowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
The advisory process for anticancer drug regulation: a global perspectiveA T Farrell, I Papadouli, A Hori, et al.
Investigational New Drugs|November 1, 1991
Phase II study of amonafide in advanced pancreatic adenocarcinomaK Linke, R Pazdur, J L Abbruzzese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study GroupD Cunningham, J Zalcberg, I Smith, et al.
Journal of Biological Response Modifiers|October 1, 1990
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicityJ L Abbruzzese, B Levin, J A Ajani, et al.
American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinomaR Pazdur, E Diaz-Canton, W P Ballard, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Cancer|February 15, 1992
A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinomaR Pazdur, J A Ajani, R Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG StudyH G Seydel, L Leichman, R Byhardt, et al.
Oncology|August 7, 1999
Fluoropyrimidines: a critical evaluationR A Brito, D Medgyesy, T H Zukowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
The advisory process for anticancer drug regulation: a global perspectiveA T Farrell, I Papadouli, A Hori, et al.
Investigational New Drugs|November 1, 1991
Phase II study of amonafide in advanced pancreatic adenocarcinomaK Linke, R Pazdur, J L Abbruzzese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study GroupD Cunningham, J Zalcberg, I Smith, et al.
Journal of Biological Response Modifiers|October 1, 1990
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicityJ L Abbruzzese, B Levin, J A Ajani, et al.
American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinomaR Pazdur, E Diaz-Canton, W P Ballard, et al.
Pageof 16